Surveillance of Lung Cancer and Mesothelioma Patients With Noncurative Treatment Intent

• Published in: Cancer nursing Vol. 45; no. 1; pp. 31 - 36
• Main Authors: Fraser, Anne, McNeill, Rob
• Format: Journal Article
• Language: English
• Published: Philadelphia Lippincott Williams & Wilkins Ovid Technologies 01-01-2022
• Subjects: Lung cancer; Mesothelioma; Patient satisfaction; Surveillance
• ISSN: 0162-220X; 1538-9804
• DOI: 10.1097/NCC.0000000000000880

BackgroundLung cancer patients with advanced disease and no active treatment options currently face frequent follow-up visits to outpatient clinics, associated with significant anxiety, time commitment, and costs. Visits also place considerable strain on the health system. Evidence from other cancers and chronic health conditions suggests virtual or remote follow-up can lead to higher patient satisfaction without negatively impacting health outcomes such as survival time.ObjectiveThe aim of this review was to identify patient preferences for, and any evidence of relative effectiveness of, different surveillance protocols for patients who have noncurative treatment intent for lung cancer or mesothelioma.Interventions/MethodsMEDLINE, PubMed, and CINAHL Plus databases were searched for articles published between 1998 and June 2018. The search was restricted to English-language publications and included all original research.ResultsNine studies met the inclusion criteria, with most studies being retrospective. Findings identified the need for reassurance and hope as part of surveillance, the importance of trust and relationship, and the lack of consistency and evidence around frequency and method of surveillance models.ConclusionsCurrent surveillance is based on expert opinion with little consideration of patient preferences, quality of life, impact on anxiety, and impact on survival outcomes.Implications for PracticeNurses play a key role in managing surveillance programs for noncurative lung cancer patients. Programs should be built using codesign approaches to ensure best outcomes. Further research needs to be conducted, ensuring directed surveillance models that meet the holistic needs of patients.